TABLE 2.
Antibodies used in this study
| Antibody | Target | Origin | Working dilution or concn | Source or reference |
|---|---|---|---|---|
| αL3,7,9 | LPS3,7,9 (4047) | Mouse monoclonal 4047 | 1/200 | NIBSC |
| αZO-1 | ZO-1 | Rabbit polyclonal | 1/30 | Zymed |
| αOcc | Occludin | Rabbit polyclonal | 1/30 | Zymed |
| αβ-tub E7 | β-Tubulin | Mouse polyclonal | 1/100 | Developmental Studies Hybridoma Bank, Iowa |
| αSM1 | PilE | Mouse monoclonal | 1/1,000 | 70 |
| αmenB 95/750 | N. meningitidis serogroup B capsule | Mouse monoclonal | NIBSC | |
| αM HRP | Mouse immunoglobulins | Goat polyclonal | 1/1,000 | Dako |
| αβ-tub E7 | β-Tubulin | Mouse polyclonal | 1/100 | Developmental Studies Hybridoma Bank, Iowa |
| αM Cy2 | Mouse IgG | Donkey polyclonal | 1/200 | Jackson |
| αM RRX | Mouse IgG | Donkey polyclonal | 1/200 | Jackson |
| αR Cy5 | Rabbit IgG | Donkey polyclonal | 1/200 | Jackson |
| 122-2 | CD46 | Mouse monoclonal | 1/50 | Santa Cruz Biotechnology, Inc. |
| 1.BB.442 | CD46 | Mouse monoclonal | 1/200 | Santa Cruz Biotechnology, Inc. |
| E4.3 | CD46 | Mouse monoclonal | 2 μg/ml | Pharmingen |
| J4.48 | CD46 | Mouse monoclonal | 2 μg/ml | Santa Cruz Biotechnology, Inc. |
| Isotype control | IgG | Mouse monoclonal | 2 μg/ml | Dako |
| Phalloidin Alexa 595 | Actin | 1/100 | Invitrogen | |
| Phalloidin Alexa 647 | Actin | 1/100 | Invitrogen |